Soligenix, Inc. Common Stock
N/A
USD
N/A
N/A
...
Chart
Financials
Description
SNGX Company Description
Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Health Solutions. It generates maximum revenue from Public Health Solutions with active development programs for RiVax, its ricin toxin vaccine candidate, SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease, and its research programs to identify and develop novel vaccine candidates targeting viral infection including Ebola, Marburg and SARS-CoV-2 (the cause of COVID-19).
SNGX Stock Smart Score
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?
Sign Up to view SNGX Smart Score
Score Breakdown
SNGX Company Description
Show More
Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Health Solutions. It generates maximum revenue from Public Health Solutions with active development programs for RiVax, its ricin toxin vaccine candidate, SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease, and its research programs to identify and develop novel vaccine candidates targeting viral infection including Ebola, Marburg and SARS-CoV-2 (the cause of COVID-19). Show Less
All
Government
Consumer Interest
SEC Filings
ESG/Other
Recent trades of SNGX by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by SNGX's directors and management
Government lobbying spending instances
U.S. Patents
New patents grants
Government Contracts
Federal grants, loans, and purchases
Twitter
Followers on SNGX's company Twitter account
WallStreetBets
Number of mentions of SNGX in WallStreetBets Daily Discussion
SNGX News
Recent insights relating to SNGX
CNBC Recommendations
Recent picks made for SNGX stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in SNGX
Corporate Flights
Flights by private jets registered to SNGX
Our Analysis